Tumor of ovary
Showing 1 - 25 of >10,000
Ovarian Cancer by Use of Circulating Tumor DNA as a Biomarker
Recruiting
- Ovarian Neoplasms
- +2 more
-
Aarhus, DenmarkDepartment of Gynaecology and Obstetrics, Aarhus University Hosp
Mar 9, 2023
Epithelioid Sarcoma (Ex-US Only), Spindle Cell Sarcoma, Sinonasal Carcinoma Trial (Tazemetostat)
Temporarily not available
- Epithelioid Sarcoma (Ex-US Only)
- +19 more
- (no location specified)
Oct 17, 2022
Stage I Testicular Seminoma, Stage I Testicular Nonseminomatous Germ Cell Tumor, Gastrointestinal Stromal Tumors Trial in
Not yet recruiting
- Stage I Testicular Seminoma
- +13 more
- Oncological Follow-up
-
Amiens, France
- +2 more
Aug 12, 2022
DKI Combined With APT for Post-treatment Assessment of Ovarian
Not yet recruiting
- Malignant Tumor of the Ovary
- XRCC2 Gene Mutation
- DKI and APT
- (no location specified)
Nov 30, 2022
Tumor Recurrence, Malignant Epithelial Tumor of Vulva, Malignant Epithelial Tumor of Ovary Trial in Pavia (carbon ion radiation
Recruiting
- Tumor Recurrence
- +3 more
- carbon ion radiation therapy
-
Pavia, Pv, ItalyCNAO
Jul 13, 2022
Elucidating Genetic Basis of Pleuropulmonary Blastoma Familial
Active, not recruiting
- Pleuropulmonary Blastoma
- +9 more
-
Washington, District of ColumbiaChildren's National Medical Center
Mar 9, 2022
Cancer of Ovary, Cancer of the Ovary, Tumors, Ovarian Trial in Pittsburgh (Cisplatin + celecoxib + DC vaccine, Cisplatin + CKM +
Suspended
- Cancer of Ovary
- +5 more
- Cisplatin + celecoxib + DC vaccine
- Cisplatin + CKM + Celecoxib + DC Vaccine
-
Pittsburgh, Pennsylvania
- +1 more
Dec 15, 2021
Carcinosarcoma, Ovarian Trial in Oklahoma City (Galunisertib, Paclitaxel, Carboplatin)
Active, not recruiting
- Carcinosarcoma, Ovarian
- Galunisertib
- +2 more
-
Oklahoma City, OklahomaStephenson Cancer Center, University of Oklahoma Health Sciences
Sep 27, 2021
Marathon of Hope Cancer Centres Network Study for Ontario
Recruiting
- Breast Cancer
- +11 more
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Jun 6, 2022
Malignant Rhabdoid Tumors (MRT), Rhabdoid Tumors of the Kidney (RTK), Atypical Teratoid Rhabdoid Tumors (ATRT) Trial in
Active, not recruiting
- Malignant Rhabdoid Tumors (MRT)
- +10 more
-
San Francisco, California
- +31 more
Jan 17, 2023
Metastatic Cancer, Metastatic Breast Cancer, Metastatic Pancreatic Cancer Trial in Marseille (IPH5301 ALONE OR IN COMBINATION
Recruiting
- Metastatic Cancer
- +8 more
- IPH5301 ALONE OR IN COMBINATION WITH CHEMOTHERAPY AND TRASTUZUMAB
-
Marseille, FranceInstitut Paoli Calmettes
Feb 23, 2022
Solid Tumor, Adult, Colorectal Cancer, NSCLC Trial in United States (A2B694, xT CDx with HLA-LOH Assay)
Not yet recruiting
- Solid Tumor, Adult
- +19 more
- A2B694
- xT CDx with HLA-LOH Assay
-
Duarte, California
- +9 more
Sep 22, 2023
Pulmonary Neuroendocrine Tumor, Pheochromocytoma, Paraganglioma Trial in Houston (177Lu-DOTATOC)
Recruiting
- Pulmonary Neuroendocrine Neoplasm
- +9 more
-
Houston, TexasExcel Diagnostics and Nuclear Oncology Center
Jul 9, 2021
Carcinosarcoma of Ovary, Carcinosarcoma of Uterus, Carcinosarcoma of Vagina Trial in Birmingham (Cabozantinib, Ipilimumab,
Withdrawn
- Carcinosarcoma of Ovary
- +2 more
- Cabozantinib
- +2 more
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Feb 18, 2021
Polycystic Ovary Syndrome
Recruiting
- Polycystic Ovary Syndrome
- This study does not involve any interventions
-
Shanghai, Shanghai, ChinaDepartment of Endocrinology, Shanghai Tenth People's Hospital
Sep 18, 2023
PCOS Trial (3-OHB (KE4), water)
Not yet recruiting
- PCOS
- 3-OHB (KE4)
- water
- (no location specified)
Mar 14, 2023
Study of Diagnostic Markers in Polycystic Ovary Syndrome
Recruiting
- Polycystic Ovary Syndrome
- This study does not involve any interventions
-
Shanghai, Shanghai, ChinaShanghai Tenth People' Hospital
Sep 6, 2022
Polycystic Ovary Syndrome Trial in Shanghai (Dihydroartemisinin)
Active, not recruiting
- Polycystic Ovary Syndrome
-
Shanghai, ChinaZhongshan Hospital Fudan University
Jul 15, 2022